Abstract

IntroductionAlthough a role of childhood body size in postmenopausal breast cancer risk has been established, less is known about its influence on tumour characteristics.MethodsWe studied the relationships between childhood body size and tumour characteristics in a Swedish population-based case-control study consisting of 2,818 breast cancer cases and 3,111 controls. Our classification of childhood body size was derived from a nine-level somatotype. Relative risks were estimated by odds ratios with 95% confidence intervals, derived from fitting unconditional logistic regression models. Association between somatotype at age 7 and tumour characteristics were evaluated in a case-only analysis where P values for heterogeneity were obtained by performing one degree of freedom trend tests.ResultsA large somatotype at age 7 was found to be associated with decreased postmenopausal breast cancer risk. Although strongly associated with other risk factors such as age of menarche, adult body mass index and mammographic density, somatotype at age 7 remained a significant protective factor (odds ratio (OR) comparing large to lean somatotype at age 7 = 0.73, 95% confidence interval (CI) = 0.58-0.91, P trend = 0.004) after adjustment. The significant protective effect was observed within all subgroups defined by estrogen receptor (ER) and progesterone receptor (PR) status, with a stronger effect for ER-negative (0.40, 95% CI = 0.21-0.75, P trend = 0.002), than for ER-positive (0.80, 95% CI = 0.62-1.05, P trend = 0.062), tumours (P heterogeneity = 0.046). Somatotype at age 7 was not associated with tumour size, histology, grade or the presence or absence of metastatic nodes.ConclusionsGreater body size at age 7 is associated with a decreased risk of postmenopausal breast cancer, and the associated protective effect is stronger for the ER-negative breast cancer subtype than for the ER-positive subtype.

Highlights

  • A role of childhood body size in postmenopausal breast cancer risk has been established, less is known about its influence on tumour characteristics

  • Age at menopause, parity, age of first birth, benign breast disease, mammographic density, recent body mass index (BMI) and use of hormone replacement therapy (HRT) were strongly significant for breast cancer risk with effects in a direction consistent with those estimated in other epidemiological studies

  • Despite somatotype one year prior to enrolment having a high correlation to recent BMI (Spearman correlation coefficient: 0.760, data not shown), it was not found to be significantly associated with breast cancer (OR per increase in somatotype class = 1.04, 95% confidence intervals (CI) = 0.94 to 1.15, P = 0.160)

Read more

Summary

Introduction

A role of childhood body size in postmenopausal breast cancer risk has been established, less is known about its influence on tumour characteristics. A study conducted in 1998 on the same data set as used in the current study [1] reported that a larger somatotype at age seven years was associated with a lower postmenopausal breast cancer risk. A role of childhood body size in adult breast cancer risk has been established, less is known about its influence on tumour characteristics. One study by Bardia and colleagues [7] looked into the risk of developing postmenopausal breast cancer stratified by estrogen receptor (ER) and progesterone receptor (PR) subtypes and reported that an increase in weight at age 12 years was BioMed Central bution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.